1887

Abstract

Introduction. LPS-responsive beige-like anchor (LRBA) protein deficiency is a disease of immune dysregulation with autoimmunity affecting various systems.

Case Presentation. Two male siblings with a novel LRBA mutation had different primary findings at admission: the younger sibling had chronic early-onset diarrhoea and the elder one had autoimmune haemolytic anaemia. During long-term follow-up for IPEX phenotype, both developed hypogammaglobulinaemia, enteropathy and lung involvement. The patients partially responded to immunosuppressive therapies. A homozygous c.2496C>A, p.Cys832Ter (p.C832*) mutation in the LRBA gene causing a premature stop codon was detected. After molecular diagnosis, abatacept, as a target-specific molecule, was used with promising results.

Conclusion. LRBA deficiency is a recently defined defect, with variable presentations in different patients; a single, definitive treatment option is thus not yet available.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Loading

Article metrics loading...

/content/journal/jmmcr/10.1099/jmmcr.0.005167
2018-10-15
2021-10-25
Loading full text...

Full text loading...

/deliver/fulltext/jmmcr/5/10/jmmcr005167.html?itemId=/content/journal/jmmcr/10.1099/jmmcr.0.005167&mimeType=html&fmt=ahah

References

  1. Picard C, Bobby Gaspar H, Al-Herz W, Bousfiha A, Casanova JL et al. International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol 2018; 38:96–128 [View Article][PubMed]
    [Google Scholar]
  2. Lopez-Herrera G, Tampella G, Pan-Hammarström Q, Herholz P, Trujillo-Vargas CM et al. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet 2012; 90:986–1001 [View Article][PubMed]
    [Google Scholar]
  3. Alangari A, Alsultan A, Adly N, Massaad MJ, Kiani IS et al. LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency. J Allergy Clin Immunol 2012; 130:481–488 [View Article][PubMed]
    [Google Scholar]
  4. Azizi G, Abolhassani H, Mahdaviani SA, Chavoshzadeh Z, Eshghi P et al. Clinical, immunologic, molecular analyses and outcomes of iranian patients with LRBA deficiency: a longitudinal study. Pediatr Allergy Immunol 2017; 28:478–484 [View Article][PubMed]
    [Google Scholar]
  5. Gámez-Díaz L, August D, Stepensky P, Revel-Vilk S, Seidel MG et al. The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency. J Allergy Clin Immunol 2016; 137:223–230 [View Article][PubMed]
    [Google Scholar]
  6. Kostel Bal S, Haskologlu S, Serwas NK, Islamoglu C, Aytekin C et al. Multiple presentations of lrba deficiency: a single-center experience. J Clin Immunol 2017; 37:790–800 [View Article][PubMed]
    [Google Scholar]
  7. Sansom DM. IMMUNOLOGY. Moving CTLA-4 from the trash to recycling. Science 2015; 349:377–378 [View Article][PubMed]
    [Google Scholar]
  8. Lo B, Zhang K, Lu W, Zheng L, Zhang Q et al. AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. Science 2015; 349:436–440 [View Article][PubMed]
    [Google Scholar]
  9. Lo B, Abdel-Motal UM. Lessons from CTLA-4 deficiency and checkpoint inhibition. Curr Opin Immunol 2017; 49:14–19 [View Article][PubMed]
    [Google Scholar]
  10. Barzaghi F, Passerini L, Bacchetta R. Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity. Front Immunol 2012; 3:211 [View Article][PubMed]
    [Google Scholar]
  11. Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 2000; 106:R75–R81 [View Article][PubMed]
    [Google Scholar]
  12. Zama D, Cocchi I, Masetti R, Specchia F, Alvisi P et al. Late-onset of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome (IPEX) with intractable diarrhea. Ital J Pediatr 2014; 40:68 [View Article][PubMed]
    [Google Scholar]
  13. Sheikine Y, Woda CB, Lee PY, Chatila TA, Keles S et al. Renal involvement in the immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) disorder. Pediatr Nephrol 2015; 30:1197–1202 [View Article][PubMed]
    [Google Scholar]
  14. Barzaghi F, Passerini L, Gambineri E, Ciullini Mannurita S, Cornu T et al. Demethylation analysis of the FOXP3 locus shows quantitative defects of regulatory T cells in IPEX-like syndrome. J Autoimmun 2012; 38:49–58 [View Article][PubMed]
    [Google Scholar]
  15. Verbsky JW, Chatila TA. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases. Curr Opin Pediatr 2013; 25:708–714 [View Article][PubMed]
    [Google Scholar]
  16. Bacchetta R, Passerini L, Gambineri E, Dai M, Allan SE et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest 2006; 116:1713–1722 [View Article][PubMed]
    [Google Scholar]
  17. D'Hennezel E, Ben-Shoshan M, Ochs HD, Torgerson TR, Russell LJ et al. FOXP3 forkhead domain mutation and regulatory T cells in the IPEX syndrome. N Engl J Med 2009; 361:1710–1713 [View Article][PubMed]
    [Google Scholar]
  18. Moes N, Rieux-Laucat F, Begue B, Verdier J, Neven B et al. Reduced expression of FOXP3 and regulatory T-cell function in severe forms of early-onset autoimmune enteropathy. Gastroenterology 2010; 139:770–778 [View Article][PubMed]
    [Google Scholar]
  19. Charbonnier LM, Janssen E, Chou J, Ohsumi TK, Keles S et al. Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA. J Allergy Clin Immunol 2015; 135:217–227 [View Article][PubMed]
    [Google Scholar]
  20. Saifi M, Wysocki CA. Autoimmune disease in primary immunodeficiency: at the crossroads of anti-infective immunity and self-tolerance. Immunol Allergy Clin North Am 2015; 35:731–752 [View Article][PubMed]
    [Google Scholar]
  21. Park JH, Levinson AI. Granulomatous-lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID). Clin Immunol 2010; 134:97–103 [View Article][PubMed]
    [Google Scholar]
  22. Rao N, Mackinnon AC, Routes JM. Granulomatous and lymphocytic interstitial lung disease: a spectrum of pulmonary histopathologic lesions in common variable immunodeficiency-histologic and immunohistochemical analyses of 16 cases. Hum Pathol 2015; 46:1306–1314 [View Article][PubMed]
    [Google Scholar]
  23. Hurst JR, Verma N, Lowe D, Baxendale HE, Jolles S et al. British lung foundation/united kingdom primary immunodeficiency network consensus statement on the definition, diagnosis, and management of granulomatous-lymphocytic interstitial lung disease in common variable immunodeficiency disorders. J Allergy Clin Immunol Pract 2017; 5:938–945 [View Article][PubMed]
    [Google Scholar]
  24. Seidel MG, Böhm K, Dogu F, Worth A, Thrasher A et al. Treatment of severe forms of LPS-responsive beige-like anchor protein deficiency with allogeneic hematopoietic stem cell transplantation. J Allergy Clin Immunol 2018; 141:770–775 [View Article][PubMed]
    [Google Scholar]
  25. Aksu G, Genel F, Koturoğlu G, Kurugöl Z, Kütükçüler N. Serum immunoglobulin (IgG, IgM, IgA) and IgG subclass concentrations in healthy children: a study using nephelometric technique. Turk J Pediatr 2006; 48:19–24[PubMed]
    [Google Scholar]
  26. Azarsiz E, Karaca NE, Aksu G, Kutukculer N. Reference values for B-cell surface markers and co-receptors associated with primary immune deficiencies in healthy Turkish children. Int J Immunopathol Pharmacol 2017; 30:194–200 [View Article][PubMed]
    [Google Scholar]
  27. Martins TB, Bandhauer ME, Bunker AM, Roberts WL, Hill HR. New childhood and adult reference intervals for total IgE. J Allergy Clin Immunol 2014; 133:589–591 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmmcr/10.1099/jmmcr.0.005167
Loading
/content/journal/jmmcr/10.1099/jmmcr.0.005167
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error